Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 939-424-4 | CAS number: 1469983-44-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- no data
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Cross-referenceopen allclose all
- Reason / purpose for cross-reference:
- reference to same study
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosome Aberration Test)
- Deviations:
- no
- Principles of method if other than guideline:
- not relevant
- GLP compliance:
- yes (incl. QA statement)
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- Diacid 1550
- IUPAC Name:
- Diacid 1550
- Details on test material:
- - Name of test material (as cited in study report): Diacid 1550
- Physical state: viscous liquid
- Lot/batch No.: Confidential
- Storage condition of test material: At room temperature
Constituent 1
Method
- Target gene:
- Not applicable
Species / strain
- Species / strain / cell type:
- Chinese hamster Ovary (CHO)
- Details on mammalian cell type (if applicable):
- - Type and identity of media: Ham's F-12 nutrient medium supplemented with 10% heat-inactivated fetal bovine serum (HIFBS) and 2 mM L-glutamine (stock medium) and medium containing 10% HIFBS, 2 mM L-glutamine, 50 units/mL of penicillin and 50 ug/mL of streptomycin (test medium).
- Properly maintained: yes - Additional strain / cell type characteristics:
- not applicable
- Metabolic activation:
- with and without
- Metabolic activation system:
- S-9 fraction and "CORE" (1:4)."CORE" = 24 mg NADP and 45 mg DL-isocitric acid per mL in deionized, distilled water
- Test concentrations with justification for top dose:
- Without metabolic activation: 150, 100, 75, 50, 25 and 13 ug/mL
With metabolic activation: 100, 75, 50, 25, 13 and 6.3 ug/mL - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: easily miscible
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- yes
- Positive control substance:
- triethylenemelamine
- cyclophosphamide
- Details on test system and experimental conditions:
- METHOD OF APPLICATION: in medium
DURATION
- Exposure duration:
Without activation: 16 hr
With activation: 2 hr
- Fixation time (start of exposure up to fixation or harvest of cells): 15.25 hours until harvested
SPINDLE INHIBITOR (cytogenetic assays): Colcmid (0.1 µg/mL), last 2 hr of incubation
STAIN (for cytogenetic assays): Giemsa stain
NUMBER OF REPLICATIONS: 4 replicate cultures (2 for cytoxicity determination in the Parallel Toxicity Test, and 2 for the evaluation of induced chromosome aberration)
NUMBER OF CELLS EVALUATED: 100 metaphases per dose
DETERMINATION OF CYTOTOXICITY
- Method: A range-finding test at the maximum concentration of 5000 µg/mL and nine lower concentrations was performed to determine the doses for the main test. Cytotoxicity was evaluated on the basis of Relative Cell Growth (RCG). Furthermore, the Average Generation Time (AGT) was determined to fix the harvest time for the main test.
OTHER EXAMINATIONS:
- Determination of polyploidy: no
- Determination of endoreplication: yes
OTHER: Validity: the assay was considered valid based on:
1 - Negative control: the number of cells with aberrations (excl. gaps and endoreplications) should not exceed 6%
2 - At least 25% of scored cells in the positive control should show one or more chomosome aberrations
3 - At least one of the scored test doses should show more than 25% reduction in the RCG - Evaluation criteria:
- A result was considered a positive response if:
1) The test article showed a positive dose-response trend and a statistically significant increase over that of the solvent controls in the number of cells with aberrations at one or more dose levels.
2) In the event there is no positive dose-response trend, at least two consecutive test doses should show a statistically significant increase in the number of cells with chromosome aberrations.
The test substance was considered to have caused an equivocal response if:
1) One of the test doses shows a statistically significant increase in the number of cells with aberrations without an accompanying positive dose-response trend.
2) The test article shows a statistically significant dose-response trend, but none of dose levels shows a significant increase in the number of cells with aberrations.
The test article was considered to have caused a negative reponse if no indication of a positive dose response was observed and none of the test doses showed a statistically significant increase in the percentage aberrant cells. - Statistics:
- A statistical analysis was not performed for the test doses since the percentage of cells with aberrations in the test dose was lower than in the solvent control both with and without metabolic activation.
The data for the positive controls were analyzed using a Chi-square test (P ≤ 0.05 was considered significant).
Results and discussion
Test results
- Species / strain:
- Chinese hamster Ovary (CHO)
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
- Remarks:
- Cytotoxic from a dose of 500 ug/mL
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Effects of osmolality: Test doses showed an osmolality value below 427
- Water solubility: formed a turbid suspension with water
- Precipitation: Precepitation was only observed at concentrations of 5000, 1000 and 500 ug/mL, not in the test doses.
- Other confounding effects: not relevant
RANGE-FINDING/SCREENING STUDIES: Calls did not survive at concentrations >500 µg/mL both with and without metabolic activation. The highest dose at which cells did not survive was 100 µg/mL, in which RCG was reduced to 54% without metabolic activation and 13% with metabolic activation.
COMPARISON WITH HISTORICAL CONTROL DATA: no information available
ADDITIONAL INFORMATION ON CYTOTOXICITY: no information available - Remarks on result:
- other: all strains/cell types tested
- Remarks:
- Migrated from field 'Test system'.
Any other information on results incl. tables
Percentage of cells with Aberrations without metabolic activation:
|
Solvent control |
Positive control |
Negative control |
Tested concentrations |
|||
100µg/mL |
75µg/mL |
50µg/mL |
25µg/ml |
||||
% of cells with aberrations |
4.0 |
58 |
4.0 |
3.0 |
3.0 |
4.0 |
1.0 |
P-value |
- |
0.000 |
- |
- |
- |
- |
- |
Percentage of cells with Aberrations with metabolic activation:
|
Solvent control |
Positive control |
Negative control |
Tested concentrations |
|||
75µg/mL |
50µg/mL |
25µg/mL |
13µg/ml |
||||
% of cells with aberrations |
3.0 |
29 |
3.0 |
2.0 |
1.0 |
2.0 |
1.0 |
P-value |
- |
0.000 |
- |
- |
- |
- |
- |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information):
negative with and without metabolic activation
In an in vitro Chromosome Aberration assay, Diacid 1550 did not cause a significant increase in the number of cells with aberrations or a positive dose response trend for concentrations of 6.3 to 100 ug/mL in Chinese Hamster Ovary Cells with and without metabolic activitation under the conditions of this test. - Executive summary:
In this study the ability of Diacid 1550 to induce chromosome aberrations in Chinese Hamster Ovary Cells was investigated. The study procedures used in this study were according to OECD Guideline 473 and the study was performed under GLP conditions..
Prior to the Chromosome Aberration assay, a miscibility test, osmolality test and a range finding test were performed in order to determine suitable doses for the main test.
In the Chromosome Aberration assay, concentrations of 150, 100, 75, 50 25, and 13 ug/mL were used without metabolic activation, whereas concentrations of 100, 75, 50, 25, 13 and 6.3 ug/mL were used with metabolic activation. Cells were exposed to the test substance for 16 hours without metabolic activation and for 2 hours with metabolic activation. After harvesting, cells were air dried and stained in Giemsa stain. A total of 100 metaphases were scored per dose for chromosome aberrations.
Diacid 1550 did not cause a significant increase in the number of cells with aberrations or a positive dose response trend for concentrations of 6.3 to 100 ug/mL in Chinese Hamster Ovary Cells with and without metabolic activitation under the conditions of this test.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.